Hollsteen
← Workday

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: $99.0M · 10-Q 0001327811-15-000014 filed Jun 5, 2015Research and development · Q2 FY2016: $115M · 10-Q 0001327811-15-000021 filed Sep 4, 2015Research and development · Q3 FY2016: $124M · 10-Q 0001327811-15-000027 filed Dec 4, 2015Research and development · Q4 FY2016: $131M · derived · 10-K 0001327811-17-000008 filed Mar 20, 2017Research and development · Q1 FY2017: $142M · 10-Q 0001327811-16-000041 filed Jun 1, 2016Research and development · Q2 FY2017: $162M · 10-Q 0001327811-16-000050 filed Sep 2, 2016Research and development · Q3 FY2017: $185M · 10-Q 0001327811-16-000062 filed Dec 2, 2016Research and development · Q4 FY2017: $192M · derived · 10-K 0001327811-18-000009 filed Mar 14, 2018Research and development · Q1 FY2018: $196M · 10-Q 0001327811-17-000015 filed Jun 2, 2017Research and development · Q2 FY2018: $221M · 10-Q 0001327811-17-000023 filed Aug 31, 2017Research and development · Q3 FY2018: $240M · 10-Q 0001327811-17-000032 filed Nov 30, 2017Research and development · Q4 FY2018: $253M · derived · 10-K 0001327811-19-000038 filed Mar 18, 2019Research and development · Q1 FY2019: $264M · 10-Q 0001327811-18-000022 filed Jun 1, 2018Research and development · Q2 FY2019: $293M · 10-Q 0001327811-18-000024 filed Sep 5, 2018Research and development · Q3 FY2019: $318M · 10-Q 0001327811-18-000058 filed Dec 3, 2018Research and development · Q4 FY2019: $337M · derived · 10-K 0001327811-20-000022 filed Mar 3, 2020Research and development · Q1 FY2020: $348M · 10-Q 0001327811-19-000092 filed May 30, 2019Research and development · Q2 FY2020: $378M · 10-Q 0001327811-19-000156 filed Aug 30, 2019Research and development · Q3 FY2020: $402M · 10-Q 0001327811-19-000196 filed Dec 4, 2019Research and development · Q4 FY2020: $422M · derived · 10-K 0001327811-21-000020 filed Mar 2, 2021Research and development · Q1 FY2021: $443M · 10-Q 0001327811-20-000070 filed May 28, 2020Research and development · Q2 FY2021: $419M · 10-Q 0001327811-20-000129 filed Aug 28, 2020Research and development · Q3 FY2021: $420M · 10-Q 0001327811-20-000167 filed Nov 20, 2020Research and development · Q4 FY2021: $439M · derived · 10-K 0001327811-22-000030 filed Feb 28, 2022Research and development · Q1 FY2022: $442M · 10-Q 0001327811-21-000054 filed May 26, 2021Research and development · Q2 FY2022: $444M · 10-Q 0001327811-21-000133 filed Aug 26, 2021Research and development · Q3 FY2022: $456M · 10-Q 0001327811-21-000174 filed Nov 18, 2021Research and development · Q4 FY2022: $538M · derived · 10-K 0001327811-23-000024 filed Feb 27, 2023Research and development · Q1 FY2023: $542M · 10-Q 0001327811-22-000091 filed May 26, 2022Research and development · Q2 FY2023: $548M · 10-Q 0001327811-22-000154 filed Aug 25, 2022Research and development · Q3 FY2023: $566M · 10-Q 0001327811-22-000184 filed Nov 29, 2022Research and development · Q4 FY2023: $616M · derived · 10-K 0001327811-24-000044 filed Mar 8, 2024Research and development · Q1 FY2024: $600M · 10-Q 0001327811-23-000078 filed May 25, 2023Research and development · Q2 FY2024: $610M · 10-Q 0001327811-23-000150 filed Aug 24, 2023Research and development · Q3 FY2024: $619M · 10-Q 0001327811-23-000202 filed Nov 28, 2023Research and development · Q4 FY2024: $635M · derived · 10-K 0001327811-25-000056 filed Mar 11, 2025Research and development · Q1 FY2025: $656M · 10-Q 0001327811-24-000093 filed May 29, 2024Research and development · Q2 FY2025: $649M · 10-Q 0001327811-24-000165 filed Aug 28, 2024Research and development · Q3 FY2025: $647M · 10-Q 0001327811-24-000242 filed Dec 5, 2024Research and development · Q4 FY2025: $674M · derived · 10-K 0001327811-26-000014 filed Mar 6, 2026Research and development · Q1 FY2026: $663M · 10-Q 0001327811-25-000107 filed May 23, 2025Research and development · Q2 FY2026: $660M · 10-Q 0001327811-25-000184 filed Aug 22, 2025Research and development · Q3 FY2026: $666M · 10-Q 0001327811-25-000198 filed Nov 26, 2025Research and development · Q4 FY2026: $691M · derived · 10-K 0001327811-26-000014 filed Mar 6, 2026Research and development · Q1 FY2027: $705M · 10-Q 0001327811-26-000026 filed May 22, 2026Research and development · Q2 FY2027: $747M · 10-Q 0001327811-26-000044 filed Aug 27, 202666074799Q1 FY2016Q2 FY2027
$MResearch and development · Q3 FY2025: $647M · 10-Q 0001327811-24-000242 filed Dec 5, 2024Research and development · Q4 FY2025: $674M · derived · 10-K 0001327811-26-000014 filed Mar 6, 2026Research and development · Q1 FY2026: $663M · 10-Q 0001327811-25-000107 filed May 23, 2025Research and development · Q2 FY2026: $660M · 10-Q 0001327811-25-000184 filed Aug 22, 2025Research and development · Q3 FY2026: $666M · 10-Q 0001327811-25-000198 filed Nov 26, 2025Research and development · Q4 FY2026: $691M · derived · 10-K 0001327811-26-000014 filed Mar 6, 2026Research and development · Q1 FY2027: $705M · 10-Q 0001327811-26-000026 filed May 22, 2026Research and development · Q2 FY2027: $747M · 10-Q 0001327811-26-000044 filed Aug 27, 2026660747647Q3 FY2025Q2 FY2027Q2 FY2026
Q2 FY2026
660$M
All values (46)
PeriodValue ($M)Status
Q2 FY2027747reported
Q1 FY2027705reported
Q4 FY2026691derived
Q3 FY2026666reported
Q2 FY2026660reported
Q1 FY2026663reported
Q4 FY2025674derived
Q3 FY2025647reported
Q2 FY2025649reported
Q1 FY2025656reported
Q4 FY2024635derived
Q3 FY2024619reported
Q2 FY2024610reported
Q1 FY2024600reported
Q4 FY2023616derived
Q3 FY2023566reported
Q2 FY2023548reported
Q1 FY2023542reported
Q4 FY2022538derived
Q3 FY2022456reported
Q2 FY2022444reported
Q1 FY2022442reported
Q4 FY2021439derived
Q3 FY2021420reported
Q2 FY2021419reported
Q1 FY2021443reported
Q4 FY2020422derived
Q3 FY2020402reported
Q2 FY2020378reported
Q1 FY2020348reported
Q4 FY2019337derived
Q3 FY2019318reported
Q2 FY2019293reported
Q1 FY2019264reported
Q4 FY2018253derived
Q3 FY2018240reported
Q2 FY2018221reported
Q1 FY2018196reported
Q4 FY2017192derived
Q3 FY2017185reported
Q2 FY2017162reported
Q1 FY2017142reported
Q4 FY2016131derived
Q3 FY2016124reported
Q2 FY2016115reported
Q1 FY201699reported

CSV with all sources · Technical ID: rnd

More metrics for Workday

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$660M
Period
Q2 FY2026, ended Jul 31, 2025 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Aug 22, 2025 · 0001327811-25-000184
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$660MAug 22, 202510-Q 0001327811-25-000184reported · confidence 1. · current